Skip to main content

Joaquin Castillo Justribo

Institutions of which they are part

Postdoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Joaquin Castillo Justribo

Institutions of which they are part

Postdoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

Estudio de la vía visual en pacientes que presentan un síndrome clínico aislado, utilidad clínica y pronóstica

IP: Angela Vidal Jordana
Collaborators: Dulce María Moncho Rodríguez, Georgina Arrambide García, Joaquin Castillo Justribo, Vanessa Carolina Thonon
Funding agency: Instituto de Salud Carlos III
Funding: 77440
Reference: PI17/02162
Duration: 01/01/2018 - 30/06/2022

Los astrocitos como diana en la prevención de la neurodegeneración en pacientes con esclerosis múltiple.

IP: Manuel Comabella Lopez
Collaborators: Joaquin Castillo Justribo
Funding agency: Instituto de Salud Carlos III
Funding: 165165
Reference: PI15/01111
Duration: 01/01/2016 - 30/11/2020

Papel de los factores hormonales relacionados con la mujer en el riesgo y pronóstico de la E.M.

IP: Mar Tintore Subirana
Collaborators: Susana Otero Romero, Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Cristina Auger Acosta, Georgina Arrambide García, Alex Rovira Cañellas, Joaquin Castillo Justribo, Milagros Fraga Pereira
Funding agency: Instituto de Salud Carlos III
Funding: 98615
Reference: PI15/00170
Duration: 01/01/2016 - 31/12/2019

Neuroimmunologia Clínica. Centre d'Esclerosi Múltiple de Catalunya (CEMCAT( (GRC)

IP: Neuroimmunologia Clínica. Centre d'Esclerosi Múltiple de Catalunya (CEMCAT( (GRC)
Collaborators: Susana Otero Romero, Carlos Nos Llopis, Neuroimmunologia Clínica. Centre d'Esclerosi Múltiple de Catalunya (CEMCAT( (GRC), José Ant. Graells Salvador, Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Margarida Capell Maymo, Carmen Tur Gomez, Neuroimmunologia Clínica. Centre d'Esclerosi Múltiple de Catalunya (CEMCAT( (GRC), Herena Eixarch Ahufinger, Carme Santoyo Medina, Oriol Nualart Mundo, Neuroimmunologia Clínica. Centre d'Esclerosi Múltiple de Catalunya (CEMCAT( (GRC), M Jesus Arevalo Navines, Dunia Muñoz Valdivielso, Carmen Espejo Ruiz, Silvia Casacuberta Serra, Sergio Vergara Ruiz, Luciana Midaglia Fernandez, Joaquin Castillo Justribo, Milagros Fraga Pereira, Breogan Rodriguez Acevedo, Mireia Castillo Juarez, Nicolás Miguel Fissolo , Georgina Arrambide García
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 50000
Reference: 2014 SGR 1082
Duration: 01/01/2014 - 31/12/2016

Related news

A study conducted at the Catalan Multiple Sclerosis Centre (Cemcat) shows that the lack of a reduction in neurofilament light chain during the first year of treatment is associated with a higher risk of subsequent disease activity.

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

Related professionals

Julia Sala Coromina

Julia Sala Coromina

Research technician
Therapeutics and Innovations in Neuropediatrics and other paediatric rare diseases
Read more
Paula Martinez Mateos

Paula Martinez Mateos

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more
Maria de la Serra Cusidó Sabidó

Maria de la Serra Cusidó Sabidó

Predoctoral researcher
Liver Diseases
Read more
Manuel Solivella Rodriguez

Manuel Solivella Rodriguez

Research technician
Microbiology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.